Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ARCK Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Get ARCK alerts:Sign Up Key Stats Today's Range$11.90▼$11.9050-Day Range$10.42▼$15.4152-Week Range$9.93▼$15.59VolumeN/AAverage VolumeN/AMarket Capitalization$256.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewArbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.Read More… Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Receive ARCK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter. Email Address ARCK Stock News HeadlinesECN Capital Corp. (ECNCF)April 18, 2024 | finance.yahoo.comSuRo Capital Corp.February 22, 2024 | wsj.comCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …October 18, 2024 | Weiss Ratings (Ad)Ready Capital Corp.February 17, 2024 | wsj.comOxford Lane Capital Corp. (OXLC)February 5, 2024 | au.finance.yahoo.comDeal Pro Capital Corporation (DPCC-P.V)January 17, 2024 | ca.finance.yahoo.comQuad 7 CapitalNovember 21, 2023 | seekingalpha.comSun Capital Management Corp (2134)November 8, 2023 | investing.comSee More Headlines ARCK Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Arbor Rapha Capital Bioholdings Corp. I own? Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), Abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI). Company Calendar Today10/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:ARCK CUSIPN/A CIK1452872 Webwww.arcgrpinc.com Phone516-506-4200FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares21,560,000Free Float302,000Market Cap$256.56 million OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:ARCK) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDon’t Buy Another Stock Until Reading This…Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my up...Unstoppable Prosperity | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbor Rapha Capital Bioholdings Corp. I Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbor Rapha Capital Bioholdings Corp. I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARCK Stock Alerts